Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry 2016 Deep Market Research Report

  • QYR382524
  • 136 Pages
  • January 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
The Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry 2016 Deep Market Research Report is a professional and in-depth study on the current state of the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 172 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents

1 Industry Overview 1

1.1 Basic Information of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 1

1.1.1 Definition of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 1

1.1.2 Classifications of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2

1.1.3 Applications of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 3

1.1.4 Characteristics of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 5

1.2 Development Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 6

1.3 Enter Barriers Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 8

2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) International and China Market Analysis 9

2.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry International Market Analysis 9

2.1.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) International Market Development History 9

2.1.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Landscape Analysis 9

2.1.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) International Main Countries Development Status 10

2.1.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) International Market Development Trend 11

2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry China Market Analysis 11

2.2.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) China Market Development History 11

2.2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Landscape Analysis 12

2.2.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) China Main Regions Development Status 12

2.2.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) China Market Development Trend 12

2.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) International and China Market Comparison Analysis 13

3 Environment Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 14

3.1 International Economy Analysis 14

3.2 China Economy Analysis 17

3.3 Policy Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 18

3.4 News Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 21

4 Analysis of Revenue by Classifications 25

4.1 Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 2010-2015 25

4.2 Global Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 2010-2015 27

4.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Classifications 29

5 Analysis of Revenue by Regions and Applications 31

5.1 Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Regions 2010-2015 31

5.2 2010-2015 USA Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 33

5.3 2010-2015 Europe Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 35

5.4 2010-2015 Japan Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 37

5.5 2010-2015 China Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 39

5.6 2010-2015 Asia-Pacific (EX. China & Japan) Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 41

5.7 2010-2015 South America Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 43

6 Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Status 2010-2015 45

6.1 Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 45

6.2 Revenue Market Share Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 47

6.3 Revenue Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 53

6.4 Gross Margin of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 55

7 Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Key Players 56

7.1 Janssen 56

7.1.1 Company Profile 56

7.1.2 Revenue and Gross Margin 57

7.1.3 Janssen SWOT Analysis 57

7.2 Qiagen 58

7.2.1 Company Profile 58

7.2.2 Revenue and Gross Margin 58

7.2.3 Qiagen SWOT Analysis 59

7.3 Advanced Cell Diagnostics 59

7.3.1 Company Profile 59

7.3.2 Revenue and Gross Margin 60

7.3.3 Advanced Cell Diagnostics SWOT Analysis 61

7.4 ApoCell 61

7.4.1 Company Profile 61

7.4.2 Revenue and Gross Margin 62

7.4.3 ApoCell SWOT Analysis 63

7.5 Biofluidica 63

7.5.1 Company Profile 63

7.5.2 Revenue and Gross Margin 64

7.5.3 Biofluidica SWOT Analysis 65

7.6 Clearbridge Biomedics 66

7.6.1 Company Profile 66

7.6.2 Revenue and Gross Margin 66

7.6.3 Clearbridge Biomedics SWOT Analysis 67

7.7 CytoTrack 68

7.7.1 Company Profile 68

7.7.2 Revenue and Gross Margin 68

7.7.3 CytoTrack SWOT Analysis 69

7.8 Celsee 69

7.8.1 Company Profile 69

7.8.2 Revenue and Gross Margin 70

7.8.3 Celsee SWOT Analysis 71

7.9 Fluxion 72

7.9.1 Company Profile 72

7.9.2 Revenue and Gross Margin 72

7.9.3 Fluxion SWOT Analysis 73

7.10 Gilupi 73

7.10.1 Company Profile 73

7.10.2 Revenue and Gross Margin 74

7.10.3 Gilupi SWOT Analysis 75

7.11 Cynvenio 75

7.11.1 Company Profile 75

7.11.2 Revenue and Gross Margin 76

7.11.3 Cynvenio SWOT Analysis 77

7.12 On-chip 77

7.12.1 Company Profile 77

7.12.2 Revenue and Gross Margin 78

7.12.3 On-chip SWOT Analysis 79

7.13 YZY Bio 79

7.13.1 Company Profile 79

7.13.2 Revenue and Gross Margin 80

7.13.3 YZY Bio SWOT Analysis 81

7.14 BioView 81

7.14.1 Company Profile 81

7.14.2 Revenue and Gross Margin 82

7.14.3 BioView SWOT Analysis 83

7.15 Creatv MicroTech 84

7.15.1 Company Profile 84

7.15.2 Revenue and Gross Margin 84

7.15.3 Creatv MicroTech SWOT Analysis 85

7.16 Fluidigm 86

7.16.1 Company Profile 86

7.16.2 Revenue and Gross Margin 86

7.16.3 Fluidigm SWOT Analysis 87

7.17 Ikonisys 87

7.17.1 Company Profile 87

7.17.2 Revenue and Gross Margin 88

7.17.3 Ikonisys SWOT Analysis 89

7.18 AdnaGen 89

7.18.1 Company Profile 89

7.18.2 Revenue and Gross Margin 90

7.18.3 AdnaGen SWOT Analysis 91

7.19 IVDiagnostics 92

7.19.1 Company Profile 92

7.19.2 Revenue and Gross Margin 93

7.19.3 IVDiagnostics SWOT Analysis 94

7.20 Miltenyi Biotec 94

7.20.1 Company Profile 94

7.20.2 Revenue and Gross Margin 95

7.20.3 Miltenyi Biotec SWOT Analysis 96

7.21 Aviva Biosciences Corporation 97

7.21.1 Company Profile 97

7.21.2 Revenue and Gross Margin 98

7.21.3 Aviva Biosciences Corporation SWOT Analysis 98

7.22 ScreenCell 99

7.22.1 Company Profile 99

7.22.2 Revenue and Gross Margin 100

7.22.3 ScreenCell SWOT Analysis 101

7.23 Silicon Biosystems 101

7.23.1 Company Profile 101

7.23.2 Revenue and Gross Margin 102

7.23.3 Silicon Biosystems SWOT Analysis 103

8 Sales Price and Gross Margin Analysis 104

8.1 Sales Price Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 104

8.2 Gross Margin Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 105

9 Marketing Trader or Distributor Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 106

9.1 Marketing Channels Status of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 106

9.2 How Countries Meet Their Needs 107

9.2.1 USA 107

9.2.2 China 107

9.2.3 Japan 108

9.2.4 Germany 109

10 Development Trend of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry 2016-2021 110

10.1 Revenue Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2016-2021 110

10.2 Sales Price Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2016-2021 110

11 Industry Chain Suppliers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with Contact Information 112

11.1 Equipment Suppliers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with Contact Information 112

11.2 Major Suppliers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with Contact Information 113

11.3 Key Consumers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with Contact Information 114

11.4 Supply Chain Relationship Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 115

12 New Project Investment Feasibility Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 116

12.1 New Project SWOT Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 116

12.2 New Project Investment Feasibility Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 116

13 Conclusion of the Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry 2015 Market Research Report 118

Tables and Figures

Figure Picture of Circulating Tumor Cells (CTCs) 1

Figure Picture of Cancer Stem Cells (CSCs) 2

Table Classifications of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2

Table Applications of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 3

Table Global Major Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players 7

Figure Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Regions 2015 10

Table Overview of the World Economic Outlook Projections 14

Figure GDP Growth (Annualized semiannual percent change) Advanced Economies, Emerging Market and Developing Economies 15

Figure Global Aggregates: Headline Inflation 16

Figure GDP Growth by Regions 16

Figure China’s GDP (% Increase on a Year Earlier) 17

Figure Price Movement of Four Chinese Mutual Funds 18

Table Policy of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 18

Table Industry News of Circulating Tumor Cells (CTCs) 21

Table Industry News of Cancer Stem Cells (CSCs) 23

Table Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 2010-2015 25

Figure 2010 Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 26

Figure 2015 Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 26

Figure Global CellSearch Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 2010-2015 27

Figure Global Oncoquick Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 2010-2015 28

Figure Global ISET Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 2010-2015 28

Figure Global MACS Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 2010-2015 29

Table USA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Classifications 29

Table Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Classifications 29

Table Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Classifications 30

Table China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Classifications 30

Table Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Regions 2010-2015 31

Figure Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Regions 2010 32

Figure Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Regions 2015 32

Figure 2010-2015 USA Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 33

Table 2010-2015 USA Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 33

Figure 2010 USA Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 34

Figure 2015 USA Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 34

Figure 2010-2015 Europe Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 35

Table 2010-2015 Europe Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 35

Figure 2010 Europe Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 36

Figure 2015 Europe Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 36

Figure 2010-2015 Japan Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 37

Table 2010-2015 Japan Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 37

Figure 2010 Japan Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 38

Figure 2015 Japan Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 38

Figure 2010-2015 China Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 39

Table 2010-2015 China Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 39

Figure 2010 China Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 40

Figure 2015 China Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 40

Figure 2010-2015 Asia-Pacific (EX. China & Japan) Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 41

Table 2010-2015 Asia-Pacific (EX. China & Japan) Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 41

Figure 2010 Asia-Pacific (EX. China & Japan) Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 42

Figure 2015 Asia-Pacific (EX. China & Japan) Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 42

Figure 2010-2015 South America Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 43

Table 2010-2015 South America Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 43

Figure 2010 South America Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 44

Figure 2015 South America Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 44

Table Revenue (Million USD) of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 45

Table Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 46

Figure 2010 Revenue Market Share Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 47

Figure 2011 Revenue Market Share Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 48

Figure 2012 Revenue Market Share Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 49

Figure 2013 Revenue Market Share Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 50

Figure 2014 Revenue Market Share Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 51

Figure 2015 Revenue Market Share Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 52

Table Revenue (Million USD) Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 53

Figure 2010 Revenue Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 53

Figure 2015 Revenue Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 54

Figure Gross Margin of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 55

Table Janssen Company Profile List 56

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Janssen 2010-2015 57

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Janssen 2010-2015 57

Table Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 57

Table Qiagen Company Profile List 58

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Qiagen 2010-2015 58

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Qiagen 2010-2015 59

Table Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 59

Table Advanced Cell Diagnostics Company Profile List 59

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Advanced Cell Diagnostics 2010-2015 60

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Advanced Cell Diagnostics 2010-2015 61

Table Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 61

Table ApoCell Company Profile List 61

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of ApoCell 2010-2015 62

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of ApoCell 2010-2015 63

Table ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 63

Table Biofluidica Company Profile List 63

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Biofluidica 2010-2015 64

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Biofluidica 2010-2015 65

Table Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 65

Table Clearbridge Biomedics Company Profile List 66

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Clearbridge Biomedics 2010-2015 66

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Clearbridge Biomedics 2010-2015 67

Table Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 67

Table CytoTrack Company Profile List 68

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of CytoTrack 2010-2015 68

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of CytoTrack 2010-2015 69

Table CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 69

Table Celsee Company Profile List 69

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Celsee 2010-2015 70

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Celsee 2010-2015 71

Table Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 71

Table Fluxion Company Profile List 72

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Fluxion 2010-2015 72

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Fluxion 2010-2015 73

Table Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 73

Table Gilupi Company Profile List 73

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Gilupi 2010-2015 74

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Gilupi 2010-2015 75

Table Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 75

Table Cynvenio Company Profile List 75

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Cynvenio 2010-2015 76

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Cynvenio 2010-2015 77

Table Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 77

Table On-chip Company Profile List 77

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of On-chip 2010-2015 78

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of On-chip 2010-2015 79

Table On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 79

Table YZY Bio Company Profile List 79

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of YZY Bio 2010-2015 80

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of YZY Bio 2010-2015 81

Table YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 81

Table BioView Company Profile List 81

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of BioView 2010-2015 82

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of BioView 2010-2015 83

Table BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 83

Table Creatv MicroTech Company Profile List 84

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Creatv MicroTech 2010-2015 84

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Creatv MicroTech 2010-2015 85

Table Creatv MicroTech Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 85

Table Fluidigm Company Profile List 86

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Fluidigm 2010-2015 86

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Fluidigm 2010-2015 87

Table Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 87

Table Ikonisys Company Profile List 87

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Ikonisys 2010-2015 88

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Ikonisys 2010-2015 89

Table Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 89

Table AdnaGen Company Profile List 89

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of AdnaGen 2010-2015 90

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of AdnaGen 2010-2015 91

Table AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 91

Table IVDiagnostics Company Profile List 92

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of IVDiagnostics 2010-2015 93

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of IVDiagnostics 2010-2015 93

Table IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 94

Table Miltenyi Biotec Company Profile List 94

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Miltenyi Biotec 2010-2015 95

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Miltenyi Biotec 2010-2015 96

Table Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 96

Table Aviva Biosciences Corporation Company Profile List 97

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Aviva Biosciences Corporation 2010-2015 98

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Aviva Biosciences Corporation 2010-2015 98

Table Aviva Biosciences Corporation Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 98

Table ScreenCell Company Profile List 99

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of ScreenCell 2010-2015 100

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of ScreenCell 2010-2015 100

Table ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 101

Table Silicon Biosystems Company Profile List 101

Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Silicon Biosystems 2010-2015 102

Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Silicon Biosystems 2010-2015 102

Table Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 103

Table Detection and Diagnosis Equipment Sales Price Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 104

Table Detection and Diagnosis Materials Sales Price Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 104

Table Detection and Diagnosis Service Sales Price Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 104

Table Gross Margin Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 105

Figure Marketing Channels Status of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 106

Table Revenue (Million USD) Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2016-2021 110

Table Detection and Diagnosis Equipment Sales Price Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2016-2021 110

Table Detection and Diagnosis Materials Sales Price Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2016-2021 111

Table Detection and Diagnosis Service Sales Price Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2016-2021 111

Table Equipment Suppliers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with Contact Information 112

Table Major Suppliers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with Contact Information 113

Table Key Consumers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with Contact Information 114

Figure Supply Chain Relationship Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 115

Table New Project SWOT Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 116

Table New Project Investment Feasibility Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 116

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370